Full Answer: GLP-1 agonists like semaglutide and tirzepatide primarily reduce body weight by suppressing appetite and improving insulin signaling
This test is rarely, if ever, done today
Hypersensitivity reactions to semaglutide or its excipients could manifest with respiratory symptoms including shortness of breath, wheezing, or throat tightness, often accompanied by other allergic signs such as rash, itching, or facial swelling
However, this also depends on the type of plan and the medical history of the patient in question. In addition to weight management, Wegovy is also FDA approved to reduce the risk of major adverse cardiovascular events in adults with cardiovascular disease and either obesity or overweight
This dual action improves energy use and fat breakdown